IL194890A0 - ANTI-VIRAL AGENTS THAT ACTIVATE RNase L - Google Patents
ANTI-VIRAL AGENTS THAT ACTIVATE RNase LInfo
- Publication number
- IL194890A0 IL194890A0 IL194890A IL19489008A IL194890A0 IL 194890 A0 IL194890 A0 IL 194890A0 IL 194890 A IL194890 A IL 194890A IL 19489008 A IL19489008 A IL 19489008A IL 194890 A0 IL194890 A0 IL 194890A0
- Authority
- IL
- Israel
- Prior art keywords
- viral agents
- activate rnase
- rnase
- activate
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79506906P | 2006-04-25 | 2006-04-25 | |
PCT/US2007/009959 WO2007127212A2 (en) | 2006-04-25 | 2007-04-25 | Anti-viral agents that activate rnase l |
Publications (1)
Publication Number | Publication Date |
---|---|
IL194890A0 true IL194890A0 (en) | 2009-08-03 |
Family
ID=38374152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL194890A IL194890A0 (en) | 2006-04-25 | 2008-10-23 | ANTI-VIRAL AGENTS THAT ACTIVATE RNase L |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2016062A2 (en) |
JP (1) | JP2009536622A (en) |
KR (1) | KR20090007609A (en) |
CN (1) | CN101460471A (en) |
AU (1) | AU2007243403A1 (en) |
CA (1) | CA2650028A1 (en) |
IL (1) | IL194890A0 (en) |
MX (1) | MX2008013668A (en) |
RU (1) | RU2008146422A (en) |
WO (1) | WO2007127212A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009123588A1 (en) * | 2008-04-01 | 2009-10-08 | The Cleveland Clinic Foundation | Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis |
EP2411001B1 (en) * | 2009-03-23 | 2018-01-17 | Merck Sharp & Dohme Corp. | P2x3, receptor antagonists for treatment of pain |
AU2012292947B2 (en) * | 2011-08-05 | 2017-02-16 | Biota Scientific Management Pty Ltd | Compounds for treating respiratory syncytial virus infections |
RU2487708C1 (en) * | 2012-03-12 | 2013-07-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздравсоцразвития России) | Method of treating parvoviral infection b19 in infants |
TWI472518B (en) * | 2014-01-02 | 2015-02-11 | Univ China Medical | Use of derivative of aniline in anti-virus application |
US20200055848A1 (en) * | 2016-11-04 | 2020-02-20 | Carna Biosciences, Inc. | Furanone derivates and methods of use thereof |
CN109745311B (en) * | 2019-02-22 | 2021-12-17 | 北京大学深圳研究生院 | Application of RNase L enzyme inhibitor |
CN112088903A (en) * | 2020-09-28 | 2020-12-18 | 武汉愔紫生物科技有限公司 | Application of macromolecular protein in antibacterial and antiviral disinfectant |
CN112107679A (en) * | 2020-09-28 | 2020-12-22 | 武汉愔紫生物科技有限公司 | Application of macromolecular protein in anti-RNA virus disinfectant |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1567112T3 (en) * | 2002-11-22 | 2009-02-09 | Smithkline Beecham Corp | Thiazolidine-4-ones to inhibit hYAK3 proteins |
US20050038051A1 (en) * | 2003-06-09 | 2005-02-17 | Jodi Nunnari | Novel molecules for regulating cell death |
WO2005016227A2 (en) * | 2003-08-14 | 2005-02-24 | Insight Biopharmaceuticals Ltd. | Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
WO2005051318A2 (en) * | 2003-11-24 | 2005-06-09 | Viropharma Incorporated | Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
WO2005082363A1 (en) * | 2004-02-20 | 2005-09-09 | Board Of Regents, The University Of Texas System | Thiazolone compounds for treatment of cancer |
JP2007523957A (en) * | 2004-02-25 | 2007-08-23 | スミスクライン・ビーチャム・コーポレイション | New chemical compounds |
-
2007
- 2007-04-25 AU AU2007243403A patent/AU2007243403A1/en not_active Abandoned
- 2007-04-25 CA CA002650028A patent/CA2650028A1/en not_active Abandoned
- 2007-04-25 CN CNA2007800208258A patent/CN101460471A/en active Pending
- 2007-04-25 WO PCT/US2007/009959 patent/WO2007127212A2/en active Application Filing
- 2007-04-25 RU RU2008146422/04A patent/RU2008146422A/en not_active Application Discontinuation
- 2007-04-25 KR KR1020087028782A patent/KR20090007609A/en not_active Application Discontinuation
- 2007-04-25 MX MX2008013668A patent/MX2008013668A/en not_active Application Discontinuation
- 2007-04-25 EP EP07755981A patent/EP2016062A2/en not_active Withdrawn
- 2007-04-25 JP JP2009507765A patent/JP2009536622A/en not_active Withdrawn
-
2008
- 2008-10-23 IL IL194890A patent/IL194890A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2008146422A (en) | 2010-05-27 |
WO2007127212A3 (en) | 2008-03-27 |
JP2009536622A (en) | 2009-10-15 |
CN101460471A (en) | 2009-06-17 |
MX2008013668A (en) | 2009-01-27 |
WO2007127212A2 (en) | 2007-11-08 |
KR20090007609A (en) | 2009-01-19 |
EP2016062A2 (en) | 2009-01-21 |
CA2650028A1 (en) | 2007-11-08 |
AU2007243403A1 (en) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2094276A4 (en) | Anti-viral compounds | |
HK1158105A1 (en) | Anti-viral agent | |
HK1165213A1 (en) | Anti-viral member | |
IL194890A0 (en) | ANTI-VIRAL AGENTS THAT ACTIVATE RNase L | |
EP2103682A4 (en) | Electromagnetic bioaccelerator | |
EP2071010A4 (en) | Grease | |
PL1854805T3 (en) | Coffee-derived surfactants | |
GB0706085D0 (en) | Briefs | |
EP2044097A4 (en) | Modified ribonucleases | |
EP2062892A4 (en) | Hypertension-ameliorating agent | |
GB0613952D0 (en) | Antiviral agent | |
EP2138172A4 (en) | Anti-viral agent | |
EP2080799A4 (en) | Grease | |
EP2030629A4 (en) | Lipid-metabolism-improving agent | |
EP1986635A4 (en) | Anticancer agents | |
GB2434342B (en) | Wheelbarrow | |
EP2060263A4 (en) | Lipid-metabolism-ameliorating agent | |
EP1867339A4 (en) | Anti-viral agent | |
ZA200708752B (en) | Component | |
GB0618588D0 (en) | Fairing | |
GB0607903D0 (en) | Bund | |
AU4360P (en) | Falcon Cordyline obtecta | |
GB0612216D0 (en) | Structural member | |
GB0612215D0 (en) | Structural member | |
GB0603824D0 (en) | Undergarments |